SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001387131-19-001273
Filing Date
2019-02-14
Accepted
2019-02-14 17:06:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE FILED TO REPORT ACQUISITION ovimd-sc13g_123118.htm SC 13G 52638
  Complete submission text file 0001387131-19-001273.txt   53915
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90350 | Film No.: 19608087
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
During Matthew (Filed by) CIK: 0001704631 (see all company filings)

Type: SC 13G